Endocrine Drugs Flashcards
Octreotide
Somatostatin analog
(GH inhibiting horone)
uses: acromegaly, suppress ectopic hormone production by tumors
goal: decrease GH and IGF-1 levels to normal
Somatotropin
recombinant GH
ROA- parenteral
Uses- pituitary dwarfism
Pegvisomant
GH receptor antagonist (binds to GH receptor but doesn’t activate JakStat or stimulate IGF-1)
uses: Acromegaly
Mecasermin
recombinant IGF-1
Laron Syndrome
Bromocriptine
dopamine analog
DA receptor agonist (D2>D1)
reduces prolactin release
given orally
used for prolacinoma, drug induced via antipsychotics or metoclopramide
adverse effects – gynecomastia, galactorrhea, inappropriate lactiation, infertility, nausea, vomiting
Desmopressin
Vasopressin analog
ROA- oral, intranasal, parenteral
MOA- v2 receptor agonist in nephron
Uses- central diabetes insipidus, von willebrand disease type I, hemophilia A, nocturnal enuresis
Sermorelin
GHRH
uses: diagnostic
orphan drug status– GH deficiency, AIDS associated weight loss
Conivaptan
v2 receptor antagonist
SIADH
Oxytocin
IV
induction of labor, postpartum uterine bleeding
Vasopressin
MOA– v1 activatior of pressor response –> inc. blood pressure
Therapeutic uses:
- advanced cardiac life support
- bleeding esophageal varices
Alprostadil
PGE1
Bimatoprost
PGF2alpha
Carboprost Tromethamine
PGF2alpha analog
IM
uses: 2nd trimester abortion, post partum hemorrhaging
diarrhea/vomiting, nausea, endometritis, sepitic shock,
Dinoprostone
PGE2
vaginal insert, gel, suppository
uses: 2nd trimester abortion, missed abortion, evacuation of fetus, cervical ripening (collagenase), hydatiform mole
fever, nausea/vomiting, abdominal pain
Latanoprost
PGF2a
irreversible brown pigmentation of eyelashes
Tafluprost
PGF2a
Travoprost
PGF2a analog
AEs: inc pigmentation of iris and periorbital tissue, elongation and growth of eyelashes
Epoprostenol
therapy of pulmonary arterial hypertension
Misoprostol
prevention of NSAID-induced gastric ulcers
induction of early abortion
T4- Levothyroxine
(hypothyroidsm)
treatment of choice for replacement therapy
IV
long half life
T3– Liothyronine
active thyroid hormone given for hypothyroidsm cardiotoxic MOA-- IV can be used for immediate therapy followed by t4 therapy
propylthiouracil (thioamine)
MOA– blocks iodination (thyroperoxidase), conjugation, and 5-deiodinase (actiaves T3 in target tissues)
-used for: mild thyrotoxicosis and preparation for subtotal thyroidectomy
slow onset of action
inhibit peripheral deiodination of T3 and T4
AE- agranulocytosis
preferred in pregnancy
Radioactive Iodine
I-131: MOA destroys thyroid gland tissue (B and gama radiation)
AE = must manage hypothyroidism with T4
I-123: emits gama particles– used for diagnosis and imaging. shorter half life than 131 (8 hrs vs 8 days)
Potassium iodide (KI)
MOA– inhibit hormone release, organificatio nad decrease size and vascularity of hyperplastic gland
Wolf-Chaikoff effect– acute inhibition of iodination of tyrosine (transient– not for long term effect)
use: thyroid storm and surgical preparation.